Applied DNA Announces Issuance of U.S. Patent Protecting its CertainT® Platform in Man-Made Cellulosic Fibers and Materials
February 07 2020 - 9:00AM
Business Wire
Newly-Issued Patent Expands the Company’s
Patent Estate in Textile Supply Chain Solutions
Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the
"Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA
manufacturing for product authenticity, traceability solutions,
nucleic acid-based biotherapeutic development and liquid biopsies,
today announced that the U.S. Patent and Trademark Office (USPTO)
has granted it United States patent no. 10,519,605 entitled
“Methods of Marking Cellulosic Products.” The newly-issued patent
covers methods of tagging man-made cellulosic (MMC) fibers or
materials with a nucleic acid (DNA) tag during production and later
authenticating the nucleic acid-tagged MMC fibers and/or materials
via PCR-based detection techniques to confirm provenance and/or
authenticity.
Global MMC production volume more than doubled from 3 million
(in 1990) to 6.7 million metric tons in 20181, and is expected to
continue to grow at an annual rate of 9% through 20242. MMCs
include viscose, Rayon, acetate, lyocell, Tencel®, modal and cupro
materials.
Most MMCs are primarily derived from wood. Heightened awareness
related to the sourcing of wood raw materials from endangered or
ancient forests, the social and environmental concerns relating to
the chemicals used in production, as well as the amount of energy
and water used to manufacture MMCs, has led to greater oversight of
the MMC industry and requires proof that these materials come from
controlled and sustainable sources that can be verified by
scientific evidence.
“The use of MMC fibers and materials is moving the textile
industry towards greater sustainability, but has also yielded
social and environmental concerns related to deforestation and
biodiversity. In response, brands and retailers, such as H&M
Group that has articulated a goal to only use MMC fibers from
certified, responsibly-managed sources in its products by 20253,
are actively strengthening their sourcing policies to address these
concerns. Central to their initiatives is traceability of their MMC
supply chains to feedstock levels,” said MeiLin Wan, Vice President
of Textile Sales at Applied DNA. “With these new patents, together
with our linear DNA-based tagging platform, we can offer MMC fiber
producers and manufacturers the unparalleled ability to ensure that
their brands are real and safe.”
“Transparency related to the source, origin and authenticity of
MMCs is the key to unlock valuable claims related to sustainable
and ethical sourcing – and this is important for the supply chain
to know that their product and brand is secure from source to
shelf,” said Wayne Buchen, Vice President of Strategic Sales at
Applied DNA. “The Company continues to collaborate with its global
network of MMC fiber producers and manufacturers to assure that
their brands are verified and traceable. With increased scrutiny of
cellulosic fibers originating from certain geographic locations, we
plan to provide solutions to enable our partners to digitally
verify their products through our CertainT portal, and also help
our brand partners to authenticate their products through
additional solutions that we offer for protecting hang tags, thread
and packaging. We are very excited to now offer our patented
technology to all stakeholders in the cellulosic fiber and
materials value chain.”
“The Company is at the forefront of large-scale PCR-based DNA
manufacture innovation as shown by its over 130 pending patent
applications and issued patents,” said Dr. James A. Hayward,
chairman, president and CEO of Applied DNA. “With the issuance of
this patent, we continue to expand the value of our proprietary
CertainT platform in textiles, which will be a key focus for fiscal
2020.”
1 Textiles Exchange, Preferred Fiber & Materials, Market
Report 2019 2
https://www.marketwatch.com/press-release/2019-24-cellulose-fiber-market-to-register-usd-39-bn-revenue-2019-07-22
3
https://hmgroup.com/sustainability/Planet/materials/Man-madeCellulosicFibres.html
About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable
supply chain security, anti-counterfeiting and anti-theft
technology, product genotyping and pre-clinical nucleic acid-based
therapeutic drug candidates.
Applied DNA makes life real and safe by providing innovative,
molecular-based technology solutions and services that can help
protect products, brands, entire supply chains, and intellectual
property of companies, governments and consumers from theft,
counterfeiting, fraud and diversion.
Visit adnas.com for more information. Follow us on Twitter and
LinkedIn. Join our mailing list.
Common stock listed on NASDAQ under the symbol APDN.
Forward-Looking Statements
The statements made by Applied DNA in this press release may be
“forward-looking” in nature within the meaning of Section 27A of
the Securities Act of 1933, Section 21E of the Securities Exchange
Act of 1934 and the Private Securities Litigation Reform Act of
1995. Forward-looking statements describe Applied DNA’s future
plans, projections, strategies and expectations, and are based on
assumptions and involve a number of risks and uncertainties, many
of which are beyond the control of Applied DNA. Actual results
could differ materially from those projected due to the possibility
of a failure to make timely payment on its outstanding secured
convertible notes and resulting enforcement by noteholders of
remedies on collateral which includes substantially all of Applied
DNA’s assets, its history of net losses, limited financial
resources, limited market acceptance, our ability to successfully
enter into commercial contracts for the implementation of our
CertainT® platform, and various other factors detailed from time to
time in Applied DNA’s SEC reports and filings, including our Annual
Report on Form 10-K filed on December 12, 2019 and other reports we
file with the SEC, which are available at www.sec.gov. Applied DNA
undertakes no obligation to update publicly any forward-looking
statements to reflect new information, events or circumstances
after the date hereof or to reflect the occurrence of unanticipated
events, unless otherwise required by law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200207005028/en/
Investor Sanjay M. Hurry, LHA Investor Relations
212-838-3777, shurry@lhai.com
Program MeiLin Wan, VP Textile Sales 631-240-8849,
meilin.wan@adnas.com
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Apr 2023 to Apr 2024